Motif BioSciences

Motif BioSciences Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel antibiotics aimed at effectively combating severe and life-threatening infections caused by multidrug-resistant Gram-positive bacteria, including MRSA.